ORIGINAL RESEARCH Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians JR DeFlavio, SA Rolin, BR Nordstrom, LA Kazal, Jr Geisel School of Medicine at Dartmouth, Hanover, New Hampshi

First Page		Document Content
Date: 2015-02-04 19:40:15 Morphinans Alcohols Drug addiction Euphoriants Drug rehabilitation Buprenorphine Drug Addiction Treatment Act Opioid replacement therapy Methadone Chemistry Medicine Organic chemistry		ORIGINAL RESEARCH Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians JR DeFlavio, SA Rolin, BR Nordstrom, LA Kazal, Jr Geisel School of Medicine at Dartmouth, Hanover, New Hampshi Add to Reading List Source URL: rrh.org.au Download Document from Source Website File Size: 233,02 KB Share Document on Facebook

	Microsoft Word - VLD Packet.FINAL DocID: 1rubZ - View Document
	Atlantic Pharmaceuticals Announces Successful Pre-IND Meeting with the FDA on Immediate Release, Abuse-Deterrent Hydrocodone Atlanta, GA., August 13, 2013. Atlantic Pharmaceuticals, Inc., a specialty pharmaceutical compa DocID: 1rtjz - View Document
	TITAN PHARMACEUTICALS CORPORATE PRESENTATION SUNIL BHONSLE JUNE 2016 © 2016 TITAN PHARMACEUTICALS INC. NASDAQ:TTNP DocID: 1rsmr - View Document
	“Hokus-Pokus Palliative Care” Case Report Gabriela Popescu, MD, M.Sc. Palliative Care, FMH Internal Medicine Tumor Zentrum and Hirslanden Klinik Aarau DocID: 1rsfZ - View Document
	Sunil Bhonsle Mar 2015 Corporate Presentation DocID: 1rrwl - View Document